Adeno-associated and herpes simplex viruses as vectors for gene transfer to the corneal endothelium

被引:45
|
作者
Hudde, T
Rayner, SA
De Alwis, M
Thrasher, AJ
Smith, J
Coffin, RS
George, AJT
Larkin, DFP
机构
[1] Moorfields Eye Hosp, London EC1V 2PD, England
[2] UCL, Dept Pathol, London, England
[3] UCL, Inst Ophthalmol, London, England
[4] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Med, Dept Immunol, London, England
[5] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Med, Div Med, London, England
[6] UCL, Mol Immunol Unit, London, England
[7] UCL, Inst Child Hlth, London, England
[8] UCL, Dept Mol Pathol, London, England
[9] UCL, Windeyer Inst Med Sci, London, England
关键词
corneal endothelium; gene transfer; AAV; HSV; vector;
D O I
10.1097/00003226-200005000-00022
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. We examined the efficacy and cytopathogenicity of adeno-associated (AAV) and herpes simplex viruses (HSV) as vectors for gene transfer to corneal endothelial cells (CECs). Methods. Recombinant AAV and HSV were examined for their ability to deliver a lacZ histochemical marker gene to whole-thickness rabbit and human corneas ex vivo. Transgene expression was detected with histochemistry and quantified by a colorimetric assay. Results, Rabbit and human corneas transduced with AAV showed increasing numbers of cells expressing marker gene over a 3- to 4-week period. Using 2.5 x 10(6) or 1.5 x 10(7) infective units for rabbit and human corneal specimens, respectively, similar to 2% of CECs expressed the reporter gene. HSV (10(6) plaque-forming units/ specimen) transduced similar to 5% of rabbit and human CECs but showed cytotoxicity. In contrast to the duration of recombinant AAV-mediated lacZ expression, recombinant HSV expression was maximal at day 1 and declined to low levels at day 7. Conclusion. AAV is a promising vector, but its usefulness for corneal transduction is currently limited by the technical difficulties preparing high titres. The HSV vector examined is efficient but needs further genetic modification to prolong transgene expression and reduce its toxicity.
引用
收藏
页码:369 / 373
页数:5
相关论文
共 50 条
  • [21] RECOMBINANT ADENO-ASSOCIATED VIRUSES AS A GENE DELIVERY VEHICLE FOR THE USE IN MOLECULAR MEDICINE
    Usman, N. Yu
    Rebrikov, D., V
    BULLETIN OF RUSSIAN STATE MEDICAL UNIVERSITY, 2021, (05): : 5 - 10
  • [22] Natural infection with adeno-associated viruses
    Dupressoir, T
    Schlehofer, JR
    ANNALES DE BIOLOGIE CLINIQUE, 1999, 57 (06) : 667 - 675
  • [23] Adeno-associated virus-mediated gene transfer
    Srivastava, Arun
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 105 (01) : 17 - 24
  • [24] Herpes simplex virus vectors for gene transfer to the nervous system
    Goins, WF
    Krisky, D
    Marconi, P
    Oligino, T
    Ramakrishnan, R
    Poliani, PL
    Fink, DJ
    Glorioso, JC
    JOURNAL OF NEUROVIROLOGY, 1997, 3 : S80 - S88
  • [25] Adeno associated viral vectors for gene transfer and gene therapy
    Büeler, H
    BIOLOGICAL CHEMISTRY, 1999, 380 (06) : 613 - 622
  • [27] The potential of adeno-associated viral vectors for gene delivery to muscle tissue
    Wang, Dan
    Zhong, Li
    Abu Nahid, M.
    Gao, Guangping
    EXPERT OPINION ON DRUG DELIVERY, 2014, 11 (03) : 345 - 364
  • [28] Recombinant adeno-associated virus vectors for cystic fibrosis gene therapy
    Flotte, TR
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2001, 3 (05) : 497 - 502
  • [29] Adeno-associated virus vectors for gene therapy-focusing on melanoma
    Wang, Xingyue
    Wei, Miao
    Miao, Rui
    Hao, Xiujing
    Li, Min
    Wang, Wenxin
    He, Zhonglei
    INTERDISCIPLINARY MEDICINE, 2024, 2 (04):
  • [30] Directed evolution of novel adeno-associated viruses for therapeutic gene delivery
    Bartel, M. A.
    Weinstein, J. R.
    Schaffer, D. V.
    GENE THERAPY, 2012, 19 (06) : 694 - 700